Oriental Aromatics Ltd (BOM:500078)
₹ 348.55 -12 (-3.33%) Market Cap: 11.73 Bil Enterprise Value: 15.61 Bil PE Ratio: 220.60 PB Ratio: 1.77 GF Score: 65/100

Q1 2025 Oriental Aromatics Ltd Earnings Call Transcript

Aug 09, 2024 / 07:30AM GMT
Release Date Price: ₹503.7 (-2.82%)

Key Points

Positve
  • Operating revenue for the quarter increased by approximately 10.3% year-on-year to INR215.8 crores.
  • EBITDA increased to INR22.2 crores, showing growth compared to previous quarters.
  • The fragrance and flavor division continues to perform strongly, acquiring new customers and growing business with existing ones.
  • Successful commissioning of the hydrogenation plant at the Vadodara site, with encouraging leads from trial productions.
  • The greenfield project in Mahad is at an advanced stage of commissioning and expected to contribute to the top line from the second half of FY 2024-2025.
Negative
  • Temporary reduction in production volumes due to routine maintenance at the Vadodara site.
  • Increase in the price of certain inputs from the fragrance division, which could impact margins.
  • Peak debt for the financial year is expected to be INR280 crores, which includes both term loans and working capital.
  • The company is cautious about the impact of geopolitical uncertainties and elections on future quarters.
  • The new capacities will take two to three quarters to reach full utilization, delaying immediate revenue benefits.
Operator

Ladies and gentlemen, good day, and welcome to Oriental Aromatics Limited Q1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Ms. Purvangi Jain from Valorem Advisors. Thank you, and over to you.

Purvangi Jain
Valorem Advisors - Investor Relations

Good afternoon, everyone, and a warm welcome to you all. My name is Purvangi Jain from Valorem Advisors. We represent Investor Relations of Oriental Aromatics Limited. On behalf of the company, I would like to thank you all for participating in the company's earnings call for the first quarter of the financial year 2025.

Before we begin, let me mention a short cautionary statement. Some of the statements made in today's earnings call may be forward-looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from those anticipated. Such statements are based on management's belief as well as assumptions made by, and information currently

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot